Ad is loading...
ABGNX
Price
$19.86
Change
-$0.18 (-0.90%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

ABGNX vs RAMHX

Header iconABGNX vs RAMHX Comparison
Open Charts ABGNX vs RAMHXBanner chart's image
American Century Balanced R5
Price$19.86
Change-$0.18 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
ABGNX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABGNX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABGNX is a Buy and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. ABGNX (938M). ABGNX (1.88) and RAMHX (1.84) have matching dividends . ABGNX was incepted earlier than RAMHX: ABGNX (8 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. ABGNX (72.00). ABGNX has a lower initial minimum investment than RAMHX: ABGNX (0) vs RAMHX (250). RAMHX annual gain was more profitable for investors over the last year : 20.31 vs. ABGNX (18.97). RAMHX return over 5 years is better than : 32.43 vs. ABGNX (8.94).
ABGNXRAMHXABGNX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years10 years-
Gain YTD12.33013.58291%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets938M236B0%
Annual Yield % from dividends1.881.84102%
Returns for 1 year18.9720.3193%
Returns for 3 years-11.239.39-120%
Returns for 5 years8.9432.4328%
Returns for 10 yearsN/A46.74-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings